외과용 지혈대 시장 : 제품 유형, 용도, 최종 사용자, 유통 채널별 - 세계 시장 예측(2026-2032년)

The Surgical Tourniquets Market is projected to grow by USD 948.30 million at a CAGR of 6.64% by 2032.

Surgical tourniquets are essential blood-management devices used to temporarily restrict arterial flow during extremity procedures, enabling clearer visualization, shorter operative steps, and more controlled bleeding management in orthopedic, trauma, reconstructive, and ambulatory surgery settings. Demand is supported by the global scale of surgery: The Lancet Commission on Global Surgery estimated that more than 300 million operations are performed worldwide annually, while also noting significant unmet need for safe surgical care.

The surgical tourniquets landscape is shaped by hospital adoption of pneumatic tourniquet systems, disposable tourniquet cuffs, pressure-regulated devices, and accessories designed to reduce contamination risk and improve operating room workflow. Adoption is closely tied to orthopedic procedure volumes, aging populations, sports injuries, road traffic trauma, and the expansion of ambulatory surgery centers, while purchasing decisions increasingly prioritize patient safety, device traceability, pressure accuracy, infection prevention, and compliance with medical device quality regulations.

Transformative Shifts in the Surgical Tourniquet Landscape

The surgical tourniquets landscape is moving from basic mechanical compression toward intelligent, pressure-controlled, and protocol-driven systems. Hospitals are shifting preference toward pneumatic surgical tourniquets with calibrated controls, alarms, reusable consoles, and single-patient-use cuffs as infection prevention and perioperative safety remain central to operating room procurement.

Another major shift is the migration of suitable orthopedic, foot and ankle, and hand procedures into ambulatory surgery centers. This setting favors compact, easy-to-clean systems, standardized cuff inventories, and training-light workflows. At the same time, regulatory expectations under frameworks such as U.S. FDA quality system requirements and the European Union Medical Device Regulation are raising the importance of documentation, post-market surveillance, biocompatibility evidence, human factors, and supplier quality management.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is beginning to influence surgical tourniquet value chains through predictive maintenance, operating room utilization analytics, inventory forecasting, and procedure-specific pressure guidance. AI-enabled analytics can help hospitals identify cuff wear patterns, reduce device downtime, and align tourniquet availability with orthopedic case schedules, supporting higher operating room efficiency and better perioperative planning.

Clinical AI adoption remains dependent on validation, cybersecurity, data governance, and regulatory classification. Any AI feature that influences clinical pressure settings or patient-specific decisions may require evidence aligned with software as a medical device expectations. The most practical near-term impact is therefore operational: improving asset management, standardizing documentation, and supporting risk alerts based on patient factors such as limb circumference, procedure duration, vascular status, anticoagulation profile, and prior complications.

Key Regional Insights

Asia-Pacific is a high-potential region for surgical tourniquets due to large patient populations, expanding hospital infrastructure, and increasing access to orthopedic and trauma surgery across China, India, Japan, South Korea, Australia, and ASEAN markets. WHO and World Bank indicators show that the region contains several of the world's most populous countries and continues to expand public and private healthcare capacity. Japan and Australia show demand for premium regulated systems supported by mature surgical standards, while India and China combine public hospital expansion with private specialty care growth and rising orthopedic procedure access.

North America remains a technology-leading region, supported by advanced surgical infrastructure, strong ambulatory surgery center penetration, high adoption of regulated medical devices, and rigorous procurement standards. Europe demonstrates steady demand under MDR-driven compliance, aging-population pressures, and established orthopedic care pathways. Latin America is supported by Brazil and Mexico's private hospital networks and trauma care needs, while the Middle East, led by GCC healthcare investment and specialty hospital development, is adopting advanced operating room systems. Africa presents long-term opportunity as trauma burden, surgical access initiatives, and hospital modernization progress, although affordability, procurement consistency, trained personnel, and after-sales service availability remain constraints.

Key Group Insights

ASEAN demand is linked to hospital modernization in Singapore, Malaysia, Thailand, Vietnam, Indonesia, and the Philippines, with procurement balancing premium pneumatic tourniquet systems for tertiary centers and cost-effective devices for broader access. GCC countries are prioritizing specialty hospitals, medical tourism, and digitally enabled operating rooms, creating favorable conditions for advanced surgical tourniquet systems, standardized clinical protocols, and service-backed procurement models.

The European Union is shaped by MDR compliance, cross-border quality expectations, and strong emphasis on patient safety, traceability, and post-market evidence. BRICS markets offer scale through large populations, rising orthopedic needs, trauma care demand, and expanding domestic medical device manufacturing. G7 markets set benchmarks for clinical evidence, reimbursement discipline, infection prevention, and high-end innovation. NATO-related defense medicine priorities also support demand for limb hemorrhage control training and trauma readiness, creating adjacent opportunities for suppliers with both surgical and emergency tourniquet portfolios.

Key Country Insights

The United States leads through high procedure volumes, ambulatory surgery center adoption, FDA-regulated procurement, and strong demand for pressure-regulated surgical tourniquet systems. Canada shows stable uptake through publicly funded surgical networks and standardized hospital purchasing, while Mexico benefits from private hospital growth, orthopedic care demand, and cross-border healthcare activity. Brazil remains the largest Latin American opportunity, supported by orthopedic demand, trauma care needs, and a sizable hospital base.

In Europe, the United Kingdom, Germany, France, Italy, and Spain maintain demand through established orthopedic and trauma care systems, national health infrastructure, and aging demographics, with Germany standing out for medical technology adoption and manufacturing strength. Russia remains influenced by localization policies, public procurement requirements, and import-related constraints. In Asia-Pacific, China and India provide scale through large patient populations and hospital expansion, Japan emphasizes quality, safety, and aging-related orthopedic care, South Korea supports technology-forward hospital adoption, and Australia demonstrates strong demand for compliant, premium surgical tourniquet systems in public and private surgical settings.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated pressure-control platforms, ergonomic cuff design, and disposable or easy-to-reprocess components that align with infection prevention policies. Product portfolios should address both premium hospitals and cost-sensitive facilities, with clear differentiation across console reliability, cuff compatibility, alarm systems, battery performance, service coverage, and documentation support.

Manufacturers should invest in education for surgeons, anesthesiologists, perioperative nurses, and biomedical engineers, because safe tourniquet use depends on correct cuff sizing, pressure selection, limb occlusion assessment, time monitoring, and equipment maintenance. Commercial teams should also strengthen evidence generation, regulatory readiness, distributor training, and post-market surveillance, while digital features such as utilization dashboards, maintenance alerts, and traceable cuff records can create recurring value beyond the initial device sale.

Research Methodology

This executive summary is developed using a structured research approach that integrates secondary sources, regulatory references, clinical practice knowledge, and evidence triangulation. Source categories include public health databases from organizations such as WHO and the World Bank, surgical access research including the Lancet Commission on Global Surgery, medical device regulatory frameworks, hospital procurement signals, perioperative safety guidance, and published clinical literature on tourniquet safety and extremity surgery.

The analysis evaluates demand drivers, technology shifts, regional healthcare infrastructure, procedure migration, regulatory conditions, and product adoption dynamics. Insights are validated through cross-comparison of macro indicators, healthcare expenditure trends, orthopedic and trauma care dynamics, ambulatory surgery expansion, infection prevention requirements, and medical device adoption patterns, ensuring that conclusions are evidence-led and suitable for strategic planning without relying on market sizing, share, or forecasting.

Conclusion

The surgical tourniquets market is evolving from a conventional operating room accessory into a safety-critical, data-supported, and workflow-integrated device category. Demand is reinforced by global surgical volume, orthopedic care needs, trauma management, aging demographics, infection prevention priorities, and the continued expansion of ambulatory surgery.

Future competitiveness will depend on clinical evidence, regulatory compliance, reliable pressure management, cuff safety, infection prevention compatibility, digital documentation, and service quality. Companies that combine proven device performance with workflow tools, regional pricing strategies, and strong clinical education will be best positioned to support adoption across mature and emerging healthcare systems.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Surgical Tourniquets Market, by Product Type

• 7.1. Non Pneumatic Tourniquets
  • 7.1.1. Elastic Tourniquets
  • 7.1.2. Mechanical Tourniquets
• 7.2. Pneumatic Tourniquets
  • 7.2.1. Multi Cuff
  • 7.2.2. Single Cuff

8. Surgical Tourniquets Market, by Application

• 8.1. Cardiovascular
  • 8.1.1. Coronary Procedures
  • 8.1.2. Peripheral Procedures
• 8.2. General Surgery
  • 8.2.1. Laparoscopy
  • 8.2.2. Open Surgery
• 8.3. Neurosurgery
  • 8.3.1. Brain Surgery
  • 8.3.2. Spinal Surgery
• 8.4. Orthopedic
  • 8.4.1. Arthroscopy
  • 8.4.2. Joint Replacement

9. Surgical Tourniquets Market, by End User

• 9.1. Ambulatory Surgery Centers
• 9.2. Hospitals
  • 9.2.1. Private Hospitals
  • 9.2.2. Public Hospitals
• 9.3. Specialty Clinics
  • 9.3.1. Orthopedic Clinics
  • 9.3.2. Vascular Clinics

10. Surgical Tourniquets Market, by Distribution Channel

• 10.1. Direct Sales
• 10.2. Distributors
  • 10.2.1. Retail Distributors
  • 10.2.2. Wholesale Distributors
• 10.3. Online Channels
  • 10.3.1. E-Commerce Platforms
  • 10.3.2. Manufacturer Websites

11. Surgical Tourniquets Market, by Region

• 11.1. Asia-Pacific
• 11.2. North America
• 11.3. Latin America
• 11.4. Europe
• 11.5. Middle East
• 11.6. Africa

12. Surgical Tourniquets Market, by Group

• 12.1. ASEAN
• 12.2. GCC
• 12.3. European Union
• 12.4. BRICS
• 12.5. G7
• 12.6. NATO

13. Surgical Tourniquets Market, by Country

• 13.1. United States
• 13.2. Canada
• 13.3. Mexico
• 13.4. Brazil
• 13.5. United Kingdom
• 13.6. Germany
• 13.7. France
• 13.8. Russia
• 13.9. Italy
• 13.10. Spain
• 13.11. China
• 13.12. India
• 13.13. Japan
• 13.14. Australia
• 13.15. South Korea

14. Competitive Landscape

• 14.1. Market Concentration Analysis, 2025
  • 14.1.1. Concentration Ratio (CR)
  • 14.1.2. Herfindahl Hirschman Index (HHI)
• 14.2. Recent Developments & Impact Analysis, 2025
• 14.3. Product Portfolio Analysis, 2025
• 14.4. Benchmarking Analysis, 2025

15. Company Profiles

• 15.1. AneticAid Ltd.
• 15.2. ConMed Corporation
• 15.3. Delfi Medical Innovations, Inc.
• 15.4. H&H Medical Corporation
• 15.5. Riester GmbH & Co. KG
• 15.6. Sam Medical, Inc.
• 15.7. Shanghai Huifeng Medical Instrument Co., Ltd.
• 15.8. Smith & Nephew plc
• 15.9. Stryker Corporation
• 15.10. Teleflex Incorporated
• 15.11. Ulrich Medical GmbH & Co. KG
• 15.12. VBM Medizintechnik GmbH
• 15.13. Zimmer Biomet Holdings, Inc.